⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEM News
Tempus AI, Inc. Class A Common Stock
Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries
businesswire.com
TEM
Nvidia’s Bet on Digital Biology and Stocks That Could Ride the Wave
globenewswire.com
RXRX
TEM
NVDA
Nvidia’s Bet on Digital Biology and Stocks That Could Ride the Wave
globenewswire.com
NVDA
RXRX
TEM
Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes
prnewswire.com
RDNT
TEM
GEHC
BFLY
Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine
businesswire.com
TEM
Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference
businesswire.com
TEM
Form 8-K
sec.gov
TEM
Tempus Reports Fourth Quarter and Full Year 2025 Results
businesswire.com
TEM
eyonis® LCS démarre sa commercialisation aux États‑Unis après l’obtention de l’autorisation FDA ; Oran Muduroglu est nommé Président de Median eyonis Inc.
businesswire.com
TEM
FDA Clearance Sets Stage for U.S. Commercialization of eyonis® LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc.
businesswire.com
TEM